The timing couldn’t have been much better.
Aurora Cannabis (NASDAQOTH:ACBFF) Chief Corporate Officer Cam Battley spoke and fielded questions in a virtual investor conference on Thursday morning.Only a couple of hours later, the Canadian Senate was scheduled to begin deliberations on legislation to legalize recreational marijuana.
As you might expect, there was plenty of discussion about Aurora’s next big potential market in Canada. However, Battley sounded even more enthusiastic about the company’s worldwide opportunities. Here are five must-see quotes from his remarks.
Image source: Getty Images.
1. Any potential delay in recreational marijuana legalization in Canada “doesn’t really affect us”
Battley noted that Thursday was “a big day” with the Canadian Senate vote on billC-45, a measure that would legalize recreational marijuana throughout the country. He said that “most bets” were for an implementation date in September 2018.
Best Canadian Stocks To Buy For 2019: TrovaGene, Inc.(TROV)
- [By Joseph Griffin]
Here are some of the news stories that may have impacted Accern’s rankings:
Get TrovaGene alerts:
Average True Range under Consideration: TrovaGene, Inc. (NASDAQ:TROV), USD Partners LP (NYSE:USDP), Tiptree … (stocksnewspoint.com) Take These As A Wake-Up Call: TrovaGene, Inc. (NASDAQ:TROV), PPDAI Group Inc. (NYSE:PPDF), Inseego Corp … (journalfinance.net) Review of Financial analysis: TrovaGene, Inc., (NASDAQ: TROV), Redwood Trust, Inc., (NYSE: RWT) (globalexportlines.com) In which scenario TrovaGene, Inc. (TROV) and Urban Outfitters, Inc. (URBN) are Trading Now? (nmsunews.com) Analysts’ Views: Sumitomo Mitsui Financial Group Inc (SMFG) and Trovagene Inc (TROV) (postregistrar.com)
TROV has been the topic of several recent research reports. Maxim Group reiterated a “hold” rating on shares of TrovaGene in a report on Monday, March 5th. HC Wainwright reiterated a “buy” rating and set a $12.00 target price on shares of TrovaGene in a report on Tuesday, March 6th. ValuEngine cut shares of TrovaGene from a “sell” rating to a “strong sell” rating in a report on Monday, April 2nd. Finally, Zacks Investment Research cut shares of TrovaGene from a “buy” rating to a “hold” rating in a report on Thursday, May 3rd. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. TrovaGene currently has an average rating of “Buy” and a consensus target price of $19.17.
- [By Paul Ausick]
TrovaGene Inc. (NASDAQ: TROV) fell more than 55% Friday to post a new 52-week low of $0.79 after closing at $1.77 on Thursday. The 52-week high is $19.56. Volume of around 11 million was nearly five times the daily average of about 230,000. The company announced a public offering of $18 million in stock and warrants priced at $1.00 for the unit.
- [By Logan Wallace]
TrovaGene Inc (NASDAQ:TROV) has been assigned a consensus rating of “Hold” from the six research firms that are currently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $7.00.
Best Canadian Stocks To Buy For 2019: Computer Programs and Systems Inc.(CPSI)
- [By Stephan Byrd]
Millrace Asset Group Inc. acquired a new position in shares of Computer Programs & Systems, Inc. (NASDAQ:CPSI) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 45,000 shares of the company’s stock, valued at approximately $1,314,000. Millrace Asset Group Inc. owned about 0.32% of Computer Programs & Systems at the end of the most recent quarter.
- [By Max Byerly]
Computer Programs & Systems, Inc. (NASDAQ:CPSI) has received an average rating of “Hold” from the nine brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, one has given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $30.80.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Computer Programs & Systems (CPSI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Computer Programs & Systems (NASDAQ: CPSI) and Perion Network Ltd Common Stock (NASDAQ:PERI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.
Best Canadian Stocks To Buy For 2019: MFS Municipal Income Trust(MFM)
- [By Ethan Ryder]
News headlines about MFS Municipal Income Trust (NYSE:MFM) have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MFS Municipal Income Trust earned a media sentiment score of 0.02 on Accern’s scale. Accern also gave news articles about the closed-end fund an impact score of 46.4351075510345 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
- [By Ethan Ryder]
Doliver Capital Advisors LP lessened its stake in MFS Municipal Income Trust (NYSE:MFM) by 51.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,505 shares of the closed-end fund’s stock after selling 20,769 shares during the period. Doliver Capital Advisors LP’s holdings in MFS Municipal Income Trust were worth $127,000 as of its most recent SEC filing.